Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 17, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transfers executed by the GlaxoSmithKline Employee Trust ("the GSK Trust") on January 16, 2007:
- 15,312 Ordinary Shares were transferred to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- 219,000 Ordinary Shares were transferred to participants in the GlaxoSmithKline Share Value Plan.
These transactions were advised to the Company on January 17, 2007.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and that three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Investor Verification Points
- Verify the total number of shares transferred to employee plans (234,312 total shares).
- Confirm the specific plans involved: SmithKline Beecham Employee Share Option Plan 1991 and GlaxoSmithKline Share Value Plan.
- Note that this filing does not reflect operational or financial performance for the period.